Free Trial

B. Metzler seel. Sohn & Co. Holding AG Buys New Position in Centene Co. (NYSE:CNC)

Centene logo with Medical background

B. Metzler seel. Sohn & Co. Holding AG purchased a new position in Centene Co. (NYSE:CNC - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 34,085 shares of the company's stock, valued at approximately $2,566,000.

Other hedge funds also recently bought and sold shares of the company. Edgestream Partners L.P. lifted its stake in Centene by 38.3% during the 1st quarter. Edgestream Partners L.P. now owns 5,636 shares of the company's stock valued at $442,000 after acquiring an additional 1,560 shares during the period. Seven Eight Capital LP bought a new position in Centene during the 1st quarter valued at about $350,000. Bessemer Group Inc. lifted its stake in Centene by 189.6% during the 1st quarter. Bessemer Group Inc. now owns 24,162 shares of the company's stock valued at $1,895,000 after acquiring an additional 15,819 shares during the period. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Centene during the 1st quarter valued at about $1,114,000. Finally, EP Wealth Advisors LLC lifted its stake in Centene by 1.0% during the 1st quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company's stock valued at $1,068,000 after acquiring an additional 133 shares during the period. Institutional investors own 93.63% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. TD Cowen upped their target price on shares of Centene from $80.00 to $89.00 and gave the company a "buy" rating in a research note on Wednesday, July 31st. Wells Fargo & Company lowered their price objective on shares of Centene from $91.00 to $90.00 and set an "overweight" rating on the stock in a research note on Monday, November 4th. Robert W. Baird lowered their price objective on shares of Centene from $83.00 to $66.00 and set a "neutral" rating on the stock in a research note on Friday, October 25th. StockNews.com cut shares of Centene from a "strong-buy" rating to a "buy" rating in a research note on Monday, October 28th. Finally, Sanford C. Bernstein lowered their price objective on shares of Centene from $96.00 to $88.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 30th. Seven analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $83.92.

Check Out Our Latest Stock Analysis on CNC

Centene Price Performance

Shares of Centene stock traded up $0.02 during mid-day trading on Friday, reaching $60.37. 4,102,533 shares of the stock traded hands, compared to its average volume of 4,037,300. The business has a 50-day moving average of $66.68 and a 200 day moving average of $70.50. Centene Co. has a fifty-two week low of $57.20 and a fifty-two week high of $81.42. The stock has a market capitalization of $30.48 billion, a PE ratio of 10.48, a PEG ratio of 0.79 and a beta of 0.49. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64.

Insider Buying and Selling at Centene

In other news, CEO Sarah London bought 4,117 shares of the business's stock in a transaction dated Friday, November 8th. The shares were acquired at an average price of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the transaction, the chief executive officer now owns 667,229 shares of the company's stock, valued at approximately $40,567,523.20. This trade represents a 0.62 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andrew Lynn Asher bought 17,200 shares of the firm's stock in a transaction that occurred on Wednesday, November 13th. The stock was purchased at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the transaction, the chief financial officer now owns 486,847 shares in the company, valued at approximately $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.33% of the stock is owned by insiders.

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Recommended Stories

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Should you invest $1,000 in Centene right now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines